COVID‐19 Vaccine Response in Pediatric Oncology Patients
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Brittni Kam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, SARS-CoV-2, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Biostatistics Shared Resource, NIH-funded Stanford Cancer Institute.
Abstract (Originalsprache)
Pediatric oncology and hematopoietic stem cell transplant (HSCT) patients may fail to mount an appropriate immune response to COVID‐19 vaccinations. The immunologic response to initial SARS‐CoV‐2 vaccination was studied in 93 pediatric patients with hematologic malignancy, solid tumors, or post‐HSCT. The majority of patients who were not receiving chemotherapy showed a positive humoral and cell‐mediated response to COVID‐19 vaccination. In contrast, variable responses to vaccination were seen in patients receiving chemotherapy. Patients with a normal lymphocyte count showed higher rates of seroconversion than their lymphocytopenic counterparts. This report details pediatric oncology and HSCT patients’ immunologic responses to COVID‐19 vaccination during all phases of treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Stanford University, Stanford, California, USA.
- Division of Biomedical Informatics Research, Stanford University, Quantitative Sciences Unit, Stanford, California, USA.
- Division of Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, California, USA.
ORCID-Profile: Brittni Kam, Catherine Aftandilian
Förderung
- Biostatistics Shared Resource
- NIH-funded Stanford Cancer Institute
Zitieren
APA
Kam, B., Wang, Y., Qin, F., Long, A. H., Klein, O. R., & Aftandilian, C. (2025). COVID‐19 Vaccine Response in Pediatric Oncology Patients. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31572
Vancouver
Kam B, Wang Y, Qin F, Long AH, Klein OR, Aftandilian C. COVID‐19 Vaccine Response in Pediatric Oncology Patients. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31572
BibTeX
@article{Kam2025,
author = {Kam, Brittni and Wang, Yiwen and Qin, FeiFei and Long, Adrienne H and Klein, Orly R and Aftandilian, Catherine},
title = {COVID‐19 Vaccine Response in Pediatric Oncology Patients},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31572}
}
EUVIMED